Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Physicists have long recognized the value of photonic graph states in quantum information processing. However, the difficulty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results